Back to Search
Start Over
KRAS Inhibitors Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Novartis, Roche, Genentech, Verastem Oncology, Revolution Medicines
- Source :
- M2 Presswire. November 20, 2024
- Publication Year :
- 2024
-
Abstract
- M2 PRESSWIRE-November 20, 2024-: KRAS Inhibitors Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Novartis, Roche, Genentech, Verastem Oncology, Revolution Medicines (C)1994-2024 M2 [...]
- Subjects :
- Novartis AG -- Forecasts and trends
Biological products industry -- Forecasts and trends
Business -- Research
Antineoplastic agents -- Forecasts and trends
Drugs -- Forecasts and trends
Epidemiology -- Forecasts and trends
Pharmaceutical industry -- Forecasts and trends
Antimitotic agents -- Forecasts and trends
Market trend/market analysis
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.816798581